Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development갑상선암과 COVID-19: 치료적 접근 및 약물 개발에 대한 전망Review Published on 2022-05-042022-09-11 Journal: Frontiers in Endocrinology [Category] COVID19(2023년), SARS, 신약개발, [키워드] Affect aggravate Autoimmune autoimmune attack Cancer cancer patient change coronavirus disease Coronavirus disease 2019 COVID-19 development Diagnosis disease drug drug target Endocrine endocrine organ global pandemic illness Immunotherapy incidence include increase in malignancy management multikinase inhibitors organ Pathogenesis prevalent promote reported Research researchers susceptible therapy Thyroid thyroid cancer Treatment with COVID-19 [DOI] 10.3389/fendo.2022.873027 PMC 바로가기 [Article Type] Review
Risk of Healthcare-Associated Transmission of Sever Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitalized Cancer PatientsArticle Published on 2022-05-032023-07-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), [키워드] Cancer COVID-19 hospital-acquired. SARS-CoV-2 [DOI] 10.1093/cid/ciab670 PMC 바로가기
COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and SafetyArticle Published on 2022-05-022023-06-16 Journal: Frontiers in Endocrinology [Category] COVID19(2023년), MERS, SARS, [키워드] Cancer COVID-19 COVID-19 vaccines Meta-analysis Neoplasms SARS-CoV-2 Seroconversion Vaccine [DOI] 10.3389/fendo.2022.860238 PMC 바로가기
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients면역 저하 환자의 COVID-19 mRNA 백신에 의한 우려 변종에 대한 체액 반응Article Published on 2022-05-012022-09-11 Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] 2019-nCoV Against age All participant All participants Alpha anti-spike antibody Antibody titer Antibody titers association Autoimmune disease Autoimmune diseases best Beta Beta variant binding BNT162b2 BNT162b2 vaccine BNT162b2 vaccines Cancer cancers circulating concern conducted COVID-19 decrease Delta delta variant Delta variants dose Effectiveness elicited enrolled female Gamma greater healthy control healthy controls hematologic Humoral response humoral responses IgG Immunocompromised patient Immunocompromised patients median Messenger RNA Moderna mRNA mRNA vaccine mRNA-1273 NAb NAb responses NAbs nCoV neutralizing antibody neutralizing antibody titers outcome participant Participants Patient patient population performed persistence Pfizer-BioNTech Primary outcome proportion proportions response response to vaccination responses against SARS-CoV-2 SARS-CoV-2 variants secondary outcome solid cancers solid organ solid organ transplant solid organ transplants study group the healthy the patient the SARS-CoV-2 Treatment underlying disease university vaccination vaccination schedule Vaccine Vaccines variant variants variants of concern VoC VOCs were measured [DOI] 10.1001/jamaoncol.2022.0446 PMC 바로가기 [Article Type] Article
Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative백신 접종을 받은 암 환자의 획기적인 COVID-19 감염의 위험과 결과: 국가 COVID 코호트 협력의 실제 증거Article Published on 2022-05-012022-09-11 Journal: Journal of clinical oncology : official journal of [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyzed BNT162b2 BNT162b2 vaccine Bone marrow Bone marrow transplantation booster Breakthrough infection breakthrough infections Cancer cancers Cohort controls COVID COVID-19 COVID-19 case COVID-19 cases COVID-19 infection COVID-19 infections Evidence hematologic Hematologic malignancy higher risk identify immunosuppressive effect increased risk leukemia Logistic regression lymphoid lymphoma malignancies medications Moderna mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA-1273 Multiple myeloma Myeloma National new SARS-CoV-2 Odds ratios outcome outcomes Patient patients Patients with cancer Pfizer ranged risk SARS-COV-2 infection SARS-CoV-2 variants Sex significantly higher smoking smoking status Solid solid tumors Tumor tumors vaccination Vaccine vaccine dose variants was reduced [DOI] 10.1200/JCO.21.02419 PMC 바로가기 [Article Type] Article
Radiotherapy treatment interruptions during the Covid-19 pandemic: The UK experience and implications for radiobiology trainingResearch article Published on 2022-05-012022-10-05 Journal: Radiation Physics and Chemistry [Category] 치료법, [키워드] Cancer caused Cell Course COVID-19 dose Frequency help implication increase in involved likelihood morbidity occur offset pandemic Patient problem Quantitative Radiation radiobiology Radiotherapy Radiotherapy treatment interruptions required risk Self-isolation Spread tissue Toxicity Treatment [DOI] 10.1016/j.radphyschem.2022.110214 [Article Type] Research article
Coincidence of Sarcoidosis and a COVID-19 vaccine-associated hypermetabolic lymphadenopathy in a patient with a history of invasive breast cancer: A case reportCase report Published on 2022-05-012022-10-05 Journal: International Journal of Surgery Case Reports [Category] 진단, [키워드] adverse event BHLbilateral hilar lymphadenopathy bilateral hilar lymphadenopathy Breast cancer Cancer Case report clinical coincidence Computed tomography Confusion COVID 19 COVID-19 diagnostic EBUS-TBNAendobronchial ultrasound-guided trans-bronchial needle aspiration endobronchial ultrasound-guided trans-bronchial needle aspiration FDG Fluorine-18 follow-up study granuloma injection invasive Lymph node malignancy multinucleated giant cell Occurrence Patient performed postoperative Region regions sarcoidosis specimen subclavicular Thyroid tomography vaccination vaccine-associated hyper metabolic lymphadenopathy VAHLvaccine-associated hyper metabolic lymphadenopathy [DOI] 10.1016/j.ijscr.2022.107098 [Article Type] Case report
Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!코로나19 팬데믹 시대 구강암 조기진단을 위한 원격검진: 진단의 함정과 잠재적인 오역!Article Published on 2022-05-012022-09-11 Journal: Oral oncology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Cancer COVID-19 pandemic [DOI] 10.1016/j.oraloncology.2022.105845 PMC 바로가기 [Article Type] Article
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study폐쇄 후 기간 동안 세포병리학 관행에 대한 COVID-19 전염병 영향: 국제, 다기관 연구Multicenter Study Published on 2022-05-012022-09-12 Journal: Cancer cytopathology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] asked Cancer cancer screening program collecting data coronavirus disease Coronavirus disease 2019 (COVID-19) country COVID-19 pandemic cytological cytopathology diagnoses difference drastic reduction evaluated fine-needle aspiration Follow-up increase in International malignancy Malignancy rate multicenter National normality pandemic participant processed ranged reduction reduction in specimen statistically significant Volume [DOI] 10.1002/cncy.22547 PMC 바로가기 [Article Type] Multicenter Study
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)Observational Study Published on 2022-05-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), SARS, 임상, 치료법, [키워드] advanced disease Cancer Care Care pathway caused Chemotherapy cohort study consequence COVID-19 COVID-19 pandemic death defined diagnose diagnosed Diagnosis disease stage dropped evaluate Follow-up French Health Impact lockdown metastatic disease Modification multicentre not different Observational cohort study oncology outbreak pancreatic Pancreatic neoplasms pandemic pathway Patient prognostic regimen SARS-CoV-2 significantly therapeutic Treatment tumour [DOI] 10.1016/j.ejca.2022.01.040 PMC 바로가기 [Article Type] Observational Study